Faron Pharma celebrates positive read-out in ongoing MDS tri

Faron Pharmaceuticals Ltd on Monday noted a positive read-out regarding the ongoing Bexmab trial on myelodysplastic syndrome, a form of cancer.

The Turku, Finland-based clinical-stage...

Related Keywords

Finland , London , City Of , United Kingdom , Samer Zeidan , Faron Pharma , Tom Budszus , Hematology Early Therapeutics Research , Alliance News Ltd , Leukemia Myeloid Malignancies At Yale Cancer Center , Faron Pharmaceuticals Ltd On , Hematologic Malignancies Division , Alliance News , Pharmaceuticals Ltd , Myeloid Malignancies , Yale Cancer , All Rights ,